Impexor Global Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 21-12-2024
- Paid Up Capital ₹ 0.25 M
as on 21-12-2024
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 56.08%
(FY 2020)
- Profit 6.12%
(FY 2020)
- Ebitda 33.30%
(FY 2020)
- Net Worth 2.63%
(FY 2020)
- Total Assets -6.15%
(FY 2020)
About Impexor Global
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.25 M, as per Ministry of Corporate Affairs (MCA) records.
Rajagopalan Viveksundar and Karthiyayini Viveksundar serve as directors at the Company.
- CIN/LLPIN
U51200TN2012PTC086730
- Company No.
086730
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jul 2012
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Impexor Global Private Limited offer?
Impexor Global Private Limited offers a wide range of products and services, including Fresh, Dried & Preserved Vegetables, Beans, Exotic Vegetables, Cereals & Food Grains, Rice, Seeds and Plant Saplings, Tree Seeds, Onion, Red Onion, Fresh Fruits.
Who are the key members and board of directors at Impexor Global?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Karthiyayini Viveksundar  | Additional Director | 05-Feb-2014 | Current |
| Rajagopalan Viveksundar | Director | 13-Jul-2012 | Current |
Financial Performance of Impexor Global.
Impexor Global Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 56.08% increase. The company also saw a slight improvement in profitability, with a 6.12% increase in profit. The company's net worth moved up by a moderate rise of 2.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Impexor Global?
In 2018, Impexor Global had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ffhp Retail LlpActive 8 years 9 monthsRajagopalan Viveksundar and Karthiyayini Viveksundar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Impexor Global?
Unlock and access historical data on people associated with Impexor Global, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Impexor Global, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Impexor Global's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
